Our Industry Partners share the ESO mission to reduce the burden of Stroke. They also support ESO’s aim to improve stroke care by providing medical education.
We are pleased to inform you about the ESO-endorsed industry webinars.
Date: Wednesday, March 8, 2023 18:30 CET
Webinar Speakers & Topics:
Prof. Cristina Gavina – Burden and risk profile in determining AF search strategies?
Prof. Georgios Tsivgoulis – Guidelines for AF detection in CS: patient risk stratification & role of insertable loop recorders
Prof. Danilo Toni – Patient Pathways and Monitoring Strategies for CS. Are progressive monitoring strategies cost effective?
Finding a diagnosis for cryptogenic stroke patients is challenging and requires a personalized approach.
Understand the latest guidance in patient risk stratification and monitoring strategies for Atrial Fibrillation in cryptogenic stroke patients.
Explore clinical and economic evidence supporting patient outcomes and cost-effectiveness of insertable loop recorders in cryptogenic stroke patients.
Webinar Speakers & Topics:
Prof. Tsivgoulis – International Guidelines for AF detection in Cryptogenic Stroke, a comprehensive overview
Prof. Mutzenbach – Neurology-led management of cryptogenic stroke patients: from theory to practice
Dr. Toquero – Cardiology perspective about practical implementation of post Stroke screening
Learn about the latest guidelines on screening for atrial fibrillation in cryptogenic stroke. Explore the CS patient journey and gain insights from the daily practice of different disciplines serving cryptogenic stroke patients. Learn why insertable cardiac monitoring is fundamental for your cryptogenic stroke patients and gather insights on how to set-up a post-stroke monitoring pathway in your practice.
Professor Geert Jan Biessels,UMC Utrecht Brain Center, The Netherlands
The program focuses on the MDT roles in the management of diabetic patients with a history or risk of stroke. Featuring a short eLearning module along with an interactive webcast, the MDT faculty (made up of neurologists, an endocrinologist and a primary care practitioner) discuss newer drug classes showing benefit in primary and secondary prevention of stroke.
Professor Maurizio Paciaroni, University of Perugia Hospital, Italy
The objective of this webinar is to discuss the management and challenges of anticoagulation in elderly and co-morbid AF patients after intracerebral haemorrhage by reviewing clinical evidence from randomized trials, real-world evidence from daily practice and by discussing clinical guidelines and practical recommendations. Professor Paciaroni will reflect on both, the management of the acute phase after a cerebrovascular event as well as long-term secondary stroke prevention in this high risk AF patient group.
Prof. Urs Fischer, Switzerland, Moderator:
“Despite recent advances in technical equipment and overall increasing reperfusion quality, still 40% of acute ischemic patients with a large vessel occlusion show a non-complete reperfusion after mechanical thrombectomy. There is a strong association between reperfusion grade achieved and functional outcome, and patients with TICI3 have a significant better outcome than patients with TICI2b. Therefore, the ESO/ESMINT guidelines currently state: “Interventionalists should attempt a TICI3 reperfusion, if achievable with reasonable safety”. However, what has to be done “right”, to achieve TICI3 in all acute ischemic stroke patients? Don’t miss this webinar during which we will discuss about the “right patient”, the “right place”, the “right treatment”, and the “right technique”!”